Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 10/2003

01-10-2003 | Rapid communication

A new clinicopathological entity of IgG4-related autoimmune disease

Authors: Terumi Kamisawa, Nobuaki Funata, Yukiko Hayashi, Yoshinobu Eishi, Morio Koike, Kouji Tsuruta, Atsutake Okamoto, Naoto Egawa, Hitoshi Nakajima

Published in: Journal of Gastroenterology | Issue 10/2003

Login to get access
Metadata
Title
A new clinicopathological entity of IgG4-related autoimmune disease
Authors
Terumi Kamisawa
Nobuaki Funata
Yukiko Hayashi
Yoshinobu Eishi
Morio Koike
Kouji Tsuruta
Atsutake Okamoto
Naoto Egawa
Hitoshi Nakajima
Publication date
01-10-2003
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 10/2003
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-003-1175-y

Other articles of this Issue 10/2003

Journal of Gastroenterology 10/2003 Go to the issue

OriginalPaper

Effects of percutaneous endoscopic gastrostomy tube placement on gastric antral motility and gastric emptying

OriginalPaper

Is intestinal BehÇet’s disease in fact an enterocolitis or an ulcer disease, and is steroid treatment useful or harmful?

OriginalPaper

Influence of anti-ulcer drugs used in Japan on the result of 13C-urea breath test for the diagnosis of Helicobacter pylori infection

Letters to the editor

Granulocyte colony stimulating factor-producing collision tumor of the gastric cardia

OriginalPaper

Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis

OriginalPaper

Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits